CME Group (CME Quick QuoteCME - Free Report) reported $1.74 billion in revenue for the quarter ended September 2026, representing a year-over-year increase of 13%. EPS of $3.02 for the same period compares to $2.68 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $1.71 billion, representing a surprise of +1.43%. The company delivered an EPS surprise of +1.34%, with the consensus EPS estimate being $2.98.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how CME performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Average daily volume: 29.45 million versus the four-analyst average estimate of 29.12 million.
• Average rate per contract- Interest rates: $0.49 versus the four-analyst average estimate of $0.48.
• Average rate per contract- Equity indexes: $0.61 versus $0.61 estimated by four analysts on average.
• Average rate per contract- Foreign exchange: $0.85 compared to the $0.82 average estimate based on four analysts.
• Average rate per contract- Energy: $1.15 versus $1.14 estimated by four analysts on average.
• Average rate per contract- Agricultural commodities: $1.38 versus $1.43 estimated by four analysts on average.
• Average daily volume- Metals: 935 thousand versus 948.26 thousand estimated by four analysts on average.
• Average rate per contract: $0.68 compared to the $0.68 average estimate based on four analysts.
• Average daily volume- Interest rates: 15.12 million compared to the 14.83 million average estimate based on four analysts.
• Revenues- Other: $116.1 million compared to the $116.04 million average estimate based on four analysts. The reported number represents a change of +8.3% year over year.
• Revenues- Market data and information services: $243.1 million compared to the $236.2 million average estimate based on four analysts. The reported number represents a change of +20.1% year over year.
• Revenues- Clearing and transaction fees: $1.38 billion versus the four-analyst average estimate of $1.36 billion. The reported number represents a year-over-year change of +12.2%.

View all Key Company Metrics for CME here>>>

Shares of CME have returned +10.5% over the past month versus the Zacks S&P 500 composite's +1% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.